Case 123: Cardiac hemosiderosis

Radiology

Volumn 245, Issue 1, 2007, Pages 292-295

  Pressacco, Josephine ^a   Elliot, Tracy L ^a   Provost, Yves ^a   Paul, Narinder ^a   Merchant, Naeem ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FEMALE; HEART HEMOSIDEROSIS; HUMAN; IMAGE ANALYSIS; IRON OVERLOAD; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; BETA-THALASSEMIA; FEMALE; HEART DISEASES; HEMOSIDEROSIS; HUMANS; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34548666655     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2451040867     Document Type: Article

References (13)

1. Mavrogeni SI, Gotsis ED, Markussis V, et al. T2 relaxation time study of iron overload in beta-thalassemia. MAGMA 1998;6(1):7-12.
2. Westwood M, Anderson LJ, Firmin DN, et al. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging 2003;18(1):33-39.
3. Forget BG. Thalassemia syndromes. In: Hoffman R, Benz EJ Jr, Shattil SJ, et al, eds. Hematology: basic principles and practice. 3rd ed. New York, NY: Churchill Livingstone, 2000; 485.
4. Adams JG 3rd, Coleman MB. Structural hemoglobin variants that produce the phenotype of thalassemia. Semin Hematol 1990;27(3):229-238.
5. Telfer PT, Prestcott K, Holden S, Walker M, Hollbrand AV, Wonke B. Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major. Br J Haematol 2000;110(4):971-977.
6. Kremastinos DT, Tsetsos GA, Tsiapras DP, Karavolias GK, Ladis VA, Kattamis CA. Heart failure in beta thalassemia: a 5-year follow-up study. Am J Med 2001;111(5):349-354.
7. Hahalis G, Manolis AS, Gerasimidou I, et al. Bight ventricular diastolic function in beta-thalassemia major: echocardiographic and clinical correlates. Am Heart J 2001;141(3):428-434.
8. Ferrara M, Matarese SM, Francese M, et al. Role of apolipoprotein E (APOE) polymorphism on left cardiac failure in homozygous beta thalassaemic patients. Br J Haematol 2001;114(4):959-900.
9. Miyata M, Smith JD. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults mid beta-amyloid peptides. Nat Genet. 1996;14(1):55-61.
10. Hahalis G, Manolis AS, Apostolopoulos D, Alexopoulos D, Vagenakis AG, Zoumbos NC. Bight ventricular cardiomyopathy in beta-thalassaemia major. Eur Heart J 2002;23(2):147-156.
11. Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood 1997;89(3):739-761.
12. Gordenk VR, Caleffi A, Corradini F, et al. Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene. Blood Cells Mol Dis 2003;31(3):299-304.
13. Beutler E, Hollbrand AV, Cook JD. Iron deficiency and overload. Hematology Am Soc Hematol Educ Program 2003:40-61.